Sector: Pharmaceuticals & Biotechnology

Small Cap

Senores Pharmaceuticals Share Price

Senores Pharmaceuticals Ltd.

₹1,095

88.00(8.74%)

Trade Now

9th Jun 2026 | 3:28 PM

NSE : SENORES

Open Free Demat Account

Senores Pharmaceuticals Performance

Price Movement

₹1095.00

₹1012.30

₹1099.90

↘ Today's Low↗ Today's High

1 Year Performance

₹1095.00

₹513.00

₹1194.40

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,099.90

Low₹1,012.30

Open at₹1,020.50

Prev Close₹1,007.00

Volumes6.89 L

Avg Price₹1,074.77

Lower Circuit₹805.60

Upper Circuit₹1,208.40

Historical Performance

3M High₹1,194.40

3M Low₹706.00

1 Yr High₹1,194.40

1 Yr Low₹513.00

3 Yr High₹1,194.40

3 Yr Low₹435.25

5 Yr High₹1,194.40

5 Yr Low₹435.25

Summary

As of 09-06-2026 23:53, Senores Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-1007.00 (-100.00%) from the previous close of ₹1007. The stock opened at ₹1020.5 and traded between ₹1012.3 and ₹1099.9, with a total traded volume of 688568 shares. The company has a market capitalization of ₹5040.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1194.4 and ₹513, respectively.

Senores Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 43.7, EPS of ₹26.39, and book value of ₹5.90. Profitability indicators show ROE of 12.35%. Senores Pharmaceuticals Ltd. has reported revenue of ₹649.5 Cr and net profit of ₹115.38 Cr.

Senores Pharmaceuticals Ltd. technical indicators include Day RSI at 48.26, Day MFI at 27.52, Day ADX at 36.17. Additional indicators include Commodity Channel Index (CCI) at -47.6 and Williams %R at -96.53. Momentum indicators show Day MACD at 30.75, Day MACD Signal Line at 48.22, DayATR at 52.06. Rate of Change indicators for Senores Pharmaceuticals Ltd. include ROC125 at 26.83 and ROC21 at 8.07.

Exponential moving averages include EMA5 at ₹1036.8, EMA10 at ₹1051.8, EMA12 at ₹1052, EMA20 at ₹1037.7, EMA26 at ₹1021.3, EMA50 at ₹962.3, EMA100 at ₹892.8, EMA200 at ₹810.2. Simple moving averages include SMA5 at ₹1032.9, SMA10 at ₹1077.5, SMA20 at ₹1056.7, SMA30 at ₹1009.2, SMA50 at ₹932.6, SMA100 at ₹859.9, SMA150 at ₹839.6, SMA200 at ₹807.8.

Support levels for Senores Pharmaceuticals are placed at First Support ₹988.90, Second Support ₹970.80, Third Support ₹940.60. Resistance levels are seen at First Resistance ₹1037.20, Second Resistance ₹1067.40, Third Resistance ₹1085.50. Senores Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 45.82%, FII holding at 3.64%, DII holding at 0%, public holding at 40.92%.

Senores Pharmaceuticals Fundamentals

Market Cap

Above industry Median

5,040.60 Cr.

PE Ratio (TTM)

Above industry Median

43.70

Dividend Yield

Net Profit TTM

140.6% incr over last year

115.38

Net Profit Growth

140.6% incr over last year

115.38

PEG Ratio

Below industry Median

0.30

ROE

66.0% incr over last year

12.35

Operating Revenue TTM

649.50

Operating Revenue Growth

103.8% incr over last year

Book Value

Above industry Median

5.90

MFI

MFI oversold

27.52

RSI

RSI is mid-range

48.26

EPS (TTM)

26.39

Debt to Equity

0.35

Face Value

Operating Profit Margin Qtr.

24.76

Operating Profit Qtr.

47.49

Net Profit Qtr.

31.61

Operating Revenue Qtr.

175.19

PB Ratio

5.90

Senores Pharmaceuticals Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	36.81	28.76	35.33	19.82	11.86
Operating Expense	40.29	29.69	33.81	20.97	14.60
Operating Profit	-3.48	-0.93	1.52	-1.15	-2.74
Depreciation	4.13	3.58	3.65	1.88	1.27
Interest	1.89	1.75	1.58	1.76	2.35
Tax	4.21	0.87	1.22	0.90	0.88
Net Profit	8.48	2.65	6.43	2.70	2.01

Senores Pharmaceuticals Technicals

Senores Pharmaceuticals Ltd. EMA & SMA

₹1095.00

88.00 (8.74%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1036.8

Day EMA10 ₹1051.8

Day EMA12 ₹1052

Day EMA20 ₹1037.7

Day EMA26 ₹1021.3

Day EMA50 ₹962.3

Day EMA100 ₹892.8

Day EMA200 ₹810.2

Senores Pharmaceuticals Support and Resistance

Resistance

First Resistance₹1037.20

Second Resistance₹1067.40

Third Resistance₹1085.50

Support

First Support₹988.90

Second Support₹970.80

Third Support₹940.60

Technical Indicators

Day RSI48.26

Day MFI27.52

Day ADX36.17

Day Commodity Channel Index-47.60

William-96.53

Day MACD30.75

Day MACD Signal Line48.22

Day ATR52.06

Day ROC12526.83

Day ROC218.07

Senores Pharmaceuticals Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	45.8	45.8	45.8	45.8	45.8	45.8
FII	4.2	4.2	3.7	4.3	3.4	3.6
DII	11.8	9.6	9.5	8.6	9.3	9.7
Public	38.2	40.4	41	41.3	41.5	40.9

Senores Pharmaceuticals Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	54.43 K	1.16 L	47.10%
Week	1.51 L	3.13 L	48.31%
1 Month	2.37 L	7.1 L	33.32%
6 Month	1.49 L	3.46 L	43.01%

Senores Pharmaceuticals SWOT Analysis

Strengths30

Weakness7

Opportunity6

Threats0

Positive Breakout Third Resistance ( LTP > R3)

High DVM Mid and Small Caps (subscription)

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Highest Recovery from 52 Week Low

High Volume, High Gain

Top Gainers

High Volume, High Gain

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Senores Pharmaceuticals Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Senores Pharmaceuticals Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.
Price (₹)	₹558.75	₹6.16	₹136.48	₹15.10	₹563.90
% Change	1.42%	-1.12%	4.30%	7.40%	1.25%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	₹176.50	₹502.55
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	₹27.81	₹57.92
PE TTM	-	-1.50	35.40	28.90	28.00
1 Year Return	42.87	515	7.51	66.37	-21.47
ROCE	3.56	-5.63	-	17.36	23.87

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 917.10

+5.41%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 73.00

-1.27%

SIGACHI

Sigachi Industries Ltd.

₹ 21.27

+0.76%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+1.94%

VINEETLAB

Vineet Laboratories Ltd.

₹ 33.50

+0.33%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 574.00

+9.35%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.05

+5.00%

MEDICO

Medico Remedies Ltd.

₹ 42.82

-1.95%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 189.00

+2.51%

LASA

Lasa Supergenerics Ltd.

₹ 7.61

-0.65%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 373.30

+0.35%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 290.05

-0.17%

ORTINGLOBE

Ortin Global Ltd.

₹ 17.93

-9.99%

BROOKS

Brooks Laboratories Ltd.

₹ 69.00

+3.51%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2110.10

+1.01%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 174.58

-10.00%

ALPA

Alpa Laboratories Ltd.

₹ 69.80

+2.29%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 380.00

+3.04%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.60

-0.34%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.40

-0.18%

INDOCO

Indoco Remedies Ltd.

₹ 207.00

+3.74%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 163.70

+4.44%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 635.50

+2.53%

PANACEABIO

Panacea Biotec Ltd.

₹ 612.00

+10.69%

FAQ's on SENORES

What is the current share price of Senores Pharmaceuticals Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Senores Pharmaceuticals Ltd. is ₹ 1095 on the NSE and ₹ 1095.1 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Senores Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Senores Pharmaceuticals Ltd. is approximately ₹ 5040.6 Cr.

What are the PE and PB ratios for Senores Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Senores Pharmaceuticals Ltd. is 43.7, and the Price-to-Book (PB) ratio is 5.9.

What is the 52-Week High and Low for Senores Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Senores Pharmaceuticals Ltd. shares was ₹ 1194.4, and the lowest price was ₹ 513.

Who are the major shareholders of Senores Pharmaceuticals Ltd.?

Significant shareholdings in Senores Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Senores Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Senores Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy